Inscrição YC de AesculaTech
AesculaTech passou pela Y Combinator no batch Winter 2018 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.
- Batch YC
- Winter 2018
- Indústria
- HealthcareMedical Devices
- Tamanho da equipe
- 6
- Status
- Active
- Lançada
- 2017
Fundadores
Niki BayatFounder/CEO
O que AesculaTech faz
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
Inscrição YC de AesculaTech, reconstruída
Inscrição Y Combinator
AesculaTech, lote Winter 2018. As verdadeiras perguntas do formulário, respondidas com dados públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
AesculaTech
Responsive materials, better lives.
We make AesculaGel, a smart, adaptive material platform that responds to stimuli and can be tailor-made for strength and biocompatibility. Our lead product, Humidifeye, uses these materials for sustained, comfortable treatment of dry eye disease by providing thermally responsive, form-fitting occlusion that adapts to patients instead of causing discomfort or extrusion like current options.
We live in Los Angeles, CA, and we would continue to be based here after YC.
Los Angeles is our home base with access to local medical experts and manufacturing partners. Staying here keeps our team close and connected to the relevant biomedical ecosystem.
21 respostas a mais na inscrição completa
Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.
Perguntas Frequentes
Esta é a inscrição real da YC de AesculaTech?
Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de AesculaTech (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como AesculaTech se apresentaria à YC, não o texto que eles submeteram.
Em qual batch da YC AesculaTech esteve?
AesculaTech fez parte do batch Winter 2018 da Y Combinator.
Quem fundou o AesculaTech?
O AesculaTech foi fundado por Niki Bayat.
O que o AesculaTech faz?
Responsive materials, better lives.
Como eu leio o application completo reconstruído?
Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do AesculaTech, e de todos os outros lotes do YC, está no YC Insights.
Mais startups YC como AesculaTech
